Roca JA, Yon-Mendoza A, Huamán N, et al. - Researchers conducted the study for analyzing the impacts of weekly postoperative intravitreal methotrexate injections on eyes with grade C proliferative vitreoretinopathy (PVR) that underwent surgical repair. It was a retrospective case-control study of 16 eyes with retinal detachment and grade C PVR. Seven eyes got weekly intravitreal MTX injections postoperatively as an adjunct, while 9 eyes served as control. For the management of PVR, serial intravitreal MTX as an adjunct to surgical repair holds promise. There was no evidence of corneal epitheliopathy.